Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 3/20 | 0.33 |
| ▸ | MMP9 | P14780 | 3/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP7 | P09237 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | PHGDH | O43175 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7603792 | 0.79 | THRB (0.39) | THRBPHGDHMEN1ALDH1A1LMNA | |
| SCHEMBL7601741 | 0.75 | MMP1 (0.30) | MMP1MMP9MMP2 | |
| SCHEMBL7573611 | 0.67 | MEN1 (0.31) | MEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL18099898 | 0.62 | MMP2 (0.45) | MMP1MMP9MMP2PHGDH | |
| SCHEMBL11778854 | 0.62 | — | — | |
| SCHEMBL8026320 | 0.62 | CYP2D6 (0.38) | ALDH1A1LMNAKMT2A | |
| SCHEMBL8552454 | 0.59 | PHGDH (0.38) | THRBPHGDHMEN1ALDH1A1LMNA | |
| SCHEMBL13515908 | 0.59 | USP2 (0.43) | MEN1ALDH1A1KMT2ACYP1A2HIF1A | |
| SCHEMBL11219832 | 0.58 | PER2 (0.33) | — | |
| SCHEMBL7112218 | 0.58 | SMN1; SMN2 (0.33) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0976738-B1 | Process for the preparation of propylene ureas | DAINIPPON INK & CHEMICALS (JP) | 2002-12-04 | — | — | EP | disclosed |
| US-6348594-B2 | HARDENING OF POLYMERS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-02-19 | — | — | US | disclosed |
| US-20020004599-A1 | PROPYLENE UREAS AND PROCESS FOR THEIR PREPARATION. | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-01-10 | — | — | US | disclosed |
| EP-0976738-A2 | Propylene ureas and the process for their preparation | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2000-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004599-A1 | PROPYLENE UREAS AND PROCESS FOR THEIR PREPARATION. | UQCRB, URB2, ADH1C | MMP1 2910/4885MMP9 3776/4885MMP2 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.